医药行业周报:和黄医药剥离中药资产,出海有望迎来新局面

德邦证券
06 Jan

(以下内容从德邦证券《医药行业周报:和黄医药剥离中药资产,出海有望迎来新局面》研报附件原文摘录)投资要点:和黄医药剥离中药资产,聚焦创新研发:和黄医药宣布达成两项协议,以6.08亿美元(人民币44.78亿元)现金向金浦健服投资管理和上海医药集团出售其在上海和黄药业有限公司(简称"上海和黄药业")的45%的股权。在2023年,和黄医药应占的上海和黄药业净收益为4,740万美元。和黄医药计划将上述...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10